| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8682413 | Clinical Neurophysiology | 2018 | 6 Pages |
Abstract
TMS measures of CST dysfunction may provide biomarkers of disease progression prior to clinical disease expression that have potential utility for monitoring neuroprotective therapies in future clinical trials.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Luis Velázquez-Pérez, Roberto RodrÃguez-Labrada, Reidenis Torres-Vega, Ricardo Ortega-Sánchez, Jacqueline Medrano-Montero, Rigoberto González-Piña, Yaimeé Vázquez-Mojena, Georg Auburger, Ulf Ziemann,